|
⚲
|
| Keyboard |
| Chapman Marcus
✚
|
|
|---|---|
| CIK # | 0001770404 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001770404] | |
| 4 | [0001770404] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Chapman Marcus | |
| Seres Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
|
2021-02-04 | Grant | 12,000 | $0.00 | |
|
Seres Therapeutics Inc MCRB
Stock Option (Right to Buy) · derivative
|
2021-02-04 | Grant | 24,000 | $0.00 | |
|
Seres Therapeutics Inc MCRB
STOCK OPTION (RIGHT TO BUY) · derivative
|
2020-04-22 | Grant | 18,596 | $0.00 | |
|
Seres Therapeutics Inc MCRB
STOCK OPTION (RIGHT TO BUY) · derivative
|
2020-01-29 | Grant | 125,000 | $0.00 | |
|
Seres Therapeutics Inc MCRB
Common Stock
|
2019-11-22 | Sell | 3,400 | $3.91 | 13,294 |
|
Seres Therapeutics Inc MCRB
Common Stock
|
2019-11-01 | Option exercise | 12,000 | $0.00 | |
|
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
|
2019-11-01 | Option exercise | 12,000 | $0.00 |